3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Thoracic
1
Breast
1
Conditions
Cardiotoxicity
5
Neoplasms
3
Breast Neoplasms
3
Heart Failure
2
Dyslipidemias
2
Cardiovascular Diseases
2
Ventricular Dysfunction, Left
1
Thoracic Neoplasms
1
Smoking
1
Pulmonary Disease, Chronic Obstructive
1
Overweight
1
Obesity
1
Noncommunicable Diseases
1
Metabolic Syndrome
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypokinesia
1
Hypertension
1
Hyperglycemia
1
Diabetes Mellitus
1
Coronary Disease
1
Cerebrovascular Disorders
1
Central Nervous System Neoplasms
1
Cardiomyopathies
1
Atrial Fibrillation
1
Asthma
1
Alcohol Drinking
1
Interventions
Blood Specimen Collection
32
Surveys and Questionnaires
24
Radiotherapy
12
Gene Expression Profiling
12
Drug Therapy
12
Surgical Procedures, Operative
11
Bronchoscopy
10
Magnetic Resonance Spectroscopy
9
Immunotherapy
9
Immunohistochemistry
9
Tomography, X-Ray Computed
8
Specimen Handling
8
Observation
8
Amplified Fragment Length Polymorphism Analysis
8
Polymerase Chain Reaction
7
pembrolizumab
6
Psychiatric Rehabilitation
6
Interviews as Topic
6
Carboplatin
6
Thoracic Surgery, Video-Assisted
5
Reverse Transcriptase Polymerase Chain Reaction
5
Microarray Analysis
5
Liquid Biopsy
5
Chemoradiotherapy
5
Bevacizumab
5
durvalumab
4
Therapeutics
4
Paclitaxel
4
Nivolumab
4
Ipilimumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Lung Neoplasms
×
Electrocardiography
×
Clear all
NCT05927246
2023-07-03
RADAF
Istanbul University
Completed
400 enrolled